Capital Deficiency (Details) - USD ($)				12 Months Ended
	Mar. 03, 2021	Feb. 19, 2021	Nov. 20, 2020	Dec. 31, 2023	Dec. 31, 2022
Capital Deficiency (Details) [Line Items]
Shares as compensation expense (in Dollars)				$ 860
Partial redemption withdrawn from investment held in trust account (in Dollars)				$ 113,000,000
Preferred shares authorized				5,000,000	5,000,000
Preferred shares par value (in Dollars per share)				$ 0.0001	$ 0.0001
Public Offering [Member]
Capital Deficiency (Details) [Line Items]
Sale of stock aggregate consideration (in Dollars)		$ 115,000,000
Private Placement [Member]
Capital Deficiency (Details) [Line Items]
Sale of stock aggregate consideration (in Dollars)	$ 3,800,000
Class A Ordinary Share [Member]
Capital Deficiency (Details) [Line Items]
Ordinary shares issued			100,000	3,354,999	480,000
Ordinary shares par value (in Dollars per share)			$ 0.0001	$ 0.0001	$ 0.0001
Number of shares issued	380,000	11,500,000
Sale price per unit (in Dollars per share)	$ 10	$ 10
Shares subject to possible redemption as temporary equity				11,500,000
Permanent equity				480,000
Class B Ordinary Shares [Member]
Capital Deficiency (Details) [Line Items]
Ordinary shares issued			2,875,000	1	2,875,000
Ordinary shares par value (in Dollars per share)			$ 0.0001	$ 0.0001	$ 0.0001
Sale of stock aggregate consideration (in Dollars)			$ 25,000
Ordinary shares issued			287,500
Number of shares subject to forfeiture			375,000
First Extensions [Member] | Class A Ordinary Share [Member]
Capital Deficiency (Details) [Line Items]
Shares subject to possible redemption as temporary equity				8,910,433
Second Extensions [Member] | Class A Ordinary Share [Member]
Capital Deficiency (Details) [Line Items]
Shares subject to possible redemption as temporary equity				2,074,548